Skip to main content
. 2021 Mar 8;17(4):1088–1100. doi: 10.7150/ijbs.56800

Figure 1.

Figure 1

GSS treatment reduced brain infarct volume and improved neurologic function in tMCAO rats. Transient MCAO rats were treated with 1.0 mg/kg GSS or equivalent vehicle as indicated, then brain infarcted volume and neurological function scores were evaluated. (A) The representative images of TTC staining for infarcted brain were shown. (B) Analysis results of brain infarcted volume. (C) Analysis results of neurological function scores. Comparisons between groups were performed using one-way ANOVA followed by Newman-Keuls test. *P<0.05 versus sham group, #P<0.05 versus tMCAO group.